al-335
Showing 1 - 9 of 9
Chronic Hepatitis C Trial in Rennes (AL-335, ACH-3102, Simeprevir)
Completed
- Chronic Hepatitis C
- AL-335
- +2 more
-
Rennes, FranceBiotrial
Oct 15, 2019
Chronic Hepatitis C Trial in Rennes, Tbilisi, Chisinau (AL-335 matching , AL-335)
Completed
- Chronic Hepatitis C
- AL-335 matching placebo
- AL-335
-
Rennes, Brittany, France
- +2 more
Oct 15, 2019
Hepatitis C, Chronic Trial in Japan (AL-335, Odalasvir (ODV), Simeprevir (SMV))
Completed
- Hepatitis C, Chronic
- AL-335
- +2 more
-
Amagasaki-shi, Japan
- +13 more
Sep 10, 2019
Healthy Trial in Surrey (Odalasvir (ODV), AL-335, Placebo)
Completed
- Healthy
- Odalasvir (ODV)
- +2 more
-
Surrey, United Kingdom(unnamed)
Mar 28, 2018
Renal Insufficiency Trial in Orlando, Knoxville (AL-335)
Completed
- Renal Insufficiency
- AL-335
-
Orlando, Florida
- +1 more
Dec 18, 2017
Healthy Trial in Overland Park (Drospirenone/ethinylestradiol, AL-335, Odalasvir (ODV))
Completed
- Healthy
- Drospirenone/ethinylestradiol
- +3 more
-
Overland Park, Kansas(unnamed)
Jan 20, 2017
Healthy Trial in Surrey (AL-335, Odalasvir (ODV), Simeprevir (SMV))
Completed
- Healthy
- AL-335
- +2 more
-
Surrey, United Kingdom(unnamed)
Nov 30, 2016